|
2025
|
Invention
|
Method for treating multiple sclerosis.
The present invention is directed to a method for treati... |
|
|
P/S
|
Advertising and marketing; Compilation of information into computer databases; Import-export agen... |
|
|
Invention
|
Cbl-b inhibitor. The present invention relates to an amide compound as a Cbl-b inhibitor or a pha... |
|
|
Invention
|
Il-17 modulators and used thereof. Compounds of Formula (I), or pharmaceutically acceptable salts... |
|
|
Invention
|
Il-17 modulators and used thereof. It relates to compounds suitable for inhibiting or regulating ... |
|
|
Invention
|
Method for treating alzheimer's disease. Provided herein is a method for treating Alzheimer's dis... |
|
|
Invention
|
Amide gspt1 degradation agent. The present invention relates to an amide compound as a GSPT1 prot... |
|
2024
|
Invention
|
Method for treating atopic dermatitis. Provided herein is a method for treating atopic dermatitis... |
|
|
Invention
|
Method for preparing orelabrutinib, and intermediate compound thereof. A method for preparing ore... |
|
|
Invention
|
Method for treating head and neck cancer.
The present invention relates to a method for treating... |
|
|
Invention
|
Amorphous solid dispersion comprising (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)e... |
|
|
Invention
|
Heterocyclic gspt1 degradation agent. The present invention relates to a heterocyclic compound as... |
|
|
Invention
|
Cbl-b inhibitor. The present invention relates to a heterocyclic compound as a Cbl-b inhibitor or... |
|
|
P/S
|
Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammator... |
|
2023
|
Invention
|
Method for treating multiple sclerosis. Provided herein is a method for treating multiple scleros... |
|
|
Invention
|
Antibody fusion protein and preparation and use thereof. An activatable antibody fusion protein, ... |
|
|
Invention
|
Antibody capable of binding to cldn18.2 or antigen-binding fragment thereof and use thereof. The ... |
|
|
Invention
|
Combination treatment with orelabrutinib and tafasitamab. Provided is the use of a combined medic... |
|
|
Invention
|
Process for preparing (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl) ethynyl)-5-(meth... |
|
|
Invention
|
Bridged bicyclic compounds as btk inhibitors.
The present invention relates to bridged bicyclic ... |
|
|
Invention
|
Heterocyclic compounds as btk inhibitors.
The present invention relates to heterocyclic compound... |
|
2022
|
Invention
|
Method for treating head and neck cancer. Provided is a method for treating head and neck cancer.... |
|
|
Invention
|
Amorphous solid dispersion comprising (s) -1- (1-acryloylpyrrolidin-3-yl) -3- ( (3, 5-dimethoxyph... |
|
|
Invention
|
Crystalline forms of (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methyl... |
|
|
Invention
|
Heterocyclic compounds as sos1 inhibitors. Provided herein are heterocyclic compounds shown in Fo... |
|
|
Invention
|
Heterocyclic compounds for inhibiting tyk2 activities. The present invention is directed to Compo... |
|
|
Invention
|
Heterocyclic compounds as kras g12c inhibitors. Provided are compounds of general Formula (I) and... |
|
2021
|
Invention
|
Heterocyclic jak inhibitor.
A heterocyclic compound as a Janus kinase (JAK) inhibitor or a pharm... |
|
|
Invention
|
Heterocyclic jak inhibitor. The present invention relates to a heterocyclic compound as a Janus k... |
|
|
P/S
|
Reagents for use in medical genetic testing; air purifying preparations; preparations for destroy... |
|
|
P/S
|
Medicines for the prevention and treatment of cancer and autoimmune diseases for human purposes; ... |
|
|
P/S
|
Medicines for human purposes; reagents for use in medical
genetic testing; cultures of microorga... |
|
|
Invention
|
Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. The present i... |
|
|
Invention
|
Heterocyclic compounds as btk inhibitors. Disclosed are heterocyclic compounds of formula (I) or ... |
|
|
Invention
|
Bridged bicyclic compounds as btk inhibitors. Provided herein are bridged bicyclic Compounds A an... |
|
|
Invention
|
Heterocyclic compound as bcl-2 inhibitor.
The present invention relates to a compound, a pharmac... |
|
|
Invention
|
Heterocyclic compound as bcl-2 inhibitor. The present invention relates to a compound, a pharmace... |
|
|
Invention
|
Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof. T... |
|
|
Invention
|
Heterocyclic immunomodulator.
The present invention relates to heterocyclic compounds as immunom... |
|
|
Invention
|
Heterocyclic immunomodulator. The present invention relates to a heterocyclic compound as an immu... |
|
|
Invention
|
Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamid... |
|
|
Invention
|
Heterocyclic compounds for inhibiting tyk2 activities. Provided are Compounds 1-8, and their phar... |
|
|
Invention
|
Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. The present in... |
|
|
Invention
|
Pyrimidin-4(3h)-one heterocyclic compound, preparation method thereof, and pharmaceutical use the... |
|
|
Invention
|
Pyrimidine-4(3h)-ketone heterocyclic compound, preparation method therefor and use thereof in med... |
|
2020
|
Invention
|
Crystalline forms of (s) -1- (1-acryloylpyrrolidin-3-yl) -3- ( (3, 5-dimethoxyphenyl) ethynyl) -5... |
|
|
Invention
|
Pyridazine-3-formamide compound, and preparation method therefor and medical use thereof. Disclos... |
|
|
Invention
|
Process for preparing 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide. Disclosed... |
|
2019
|
Invention
|
Amorphous solid dispersion comprising 6- (1-acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotin... |
|
|
Invention
|
Heterocyclic compound as trk inhibitor. The present invention relates to a compound, a pharmaceut... |
|
|
Invention
|
3-oxazolinone compound, preparation method therefor and pharmaceutical application thereof.
The ... |
|
|
Invention
|
Indoline-1-formamide compound, preparation method therefor, and medical use thereof. Disclosed ar... |
|
|
Invention
|
Pentafluorosulfanyl-substituted amide derivatives, preparation methods thereof and medical uses t... |
|
|
P/S
|
Marketing; public relations; retail or wholesale services
for pharmaceutical, veterinary and san... |
|
|
P/S
|
Air purifying preparations; pharmaceutical preparations;
dietetic substances adapted for medical... |
|
|
P/S
|
Oil refining services; material treatment information; food and drink preservation; bookbinding; ... |
|
|
P/S
|
Providing material treatment information; Custom processing of chemical reagents at the specifica... |
|
|
P/S
|
Medicines for human purposes; diagnostic preparations for
medical purposes; pharmaceutical prepa... |
|
|
P/S
|
Diagnostic preparations for medical purposes; nutritional
supplements; medicines for human purpo... |
|
2018
|
P/S
|
Public relations; professional business consultancy;
personnel management consultancy; organizat... |
|
|
P/S
|
Marketing; personnel management consultancy; organization of
exhibitions for commercial or adver... |
|
|
P/S
|
Botanicals for the treatment of stomach ulcers; dietetic substances consisting of vitamins, miner... |
